share_log

In8bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-William Tai-Wei Ho(7.1%)

SEC announcement ·  Feb 13 16:06
Summary by Moomoo AI
William Tai-Wei Ho has filed an amended Schedule 13G with the United States Securities and Exchange Commission on February 13, 2024, indicating a change in his holdings of In8bio, Inc. As of December 31, 2023, Ho reported beneficial ownership of 3,126,505 shares of In8bio's common stock, which represents 7.1% of the company's class of securities. This stake includes 2,421,512 shares held directly, 449,494 shares underlying immediately exercisable options, and additional shares held by Ho's minor children and other relatives. The filing was made in accordance with the Securities Exchange Act of 1934 and reflects Ho's holdings as of the end of 2023. In8bio, Inc., headquartered at 350 5th Avenue, Suite 5330, New York, NY, is a Delaware corporation listed on the United States stock market.
William Tai-Wei Ho has filed an amended Schedule 13G with the United States Securities and Exchange Commission on February 13, 2024, indicating a change in his holdings of In8bio, Inc. As of December 31, 2023, Ho reported beneficial ownership of 3,126,505 shares of In8bio's common stock, which represents 7.1% of the company's class of securities. This stake includes 2,421,512 shares held directly, 449,494 shares underlying immediately exercisable options, and additional shares held by Ho's minor children and other relatives. The filing was made in accordance with the Securities Exchange Act of 1934 and reflects Ho's holdings as of the end of 2023. In8bio, Inc., headquartered at 350 5th Avenue, Suite 5330, New York, NY, is a Delaware corporation listed on the United States stock market.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more